The U.S. Food and Drug Administration has approved a new topical gel to help treat symptoms of overactive bladder. Gelnique is a once-daily topical dose of oxybutynin chloride gel that is applied to the thigh, abdomen, upper arm, or shoulder. Researchers say that because the gel is delivered through the skin it is not metabolized in the liver, which means patients may see fewer side effects such as dry mouth and constipation. The drug’s maker says the gel will be available in spring 2009.
Hello HC Readers,I came across this article after reading my MS World Express newsletter. I thought I would share it with you. I did... Read more »
For patients with chronic pain involving limited areas of the body, they might not have to expose themselves to the toxicities of... Read more »
Drugmaker Watson Pharmaceuticals is reporting that data from three new studies shows that its new topical treatment for overactive bladder syndrome... Read more »
Research presented at the International AIDS Conference has found that a vaginal gel reduced women's risk of becoming infected with HIV by 39 percent... Read more »
U.S. researchers have developed a type of gel that helps spur cartilage growth in joints. The nanofiber gel is injected into a damaged joint where it... Read more »
Officials with drugmaker Starpharma Holdings Ltd. say the company plans to release the first herpes-killing vaginal gel within the next two years.... Read more »
Officials with the U.S. Food and Drug Administration (FDA) have issued warnings to eight companies for illegally selling pain-relief gels that... Read more »